114 Real-World Use of ACE Inhibitors and ARBs in Sickle Cell Disease: Evaluating Prescribing Patterns and Missed Opportunities in Microalbuminuria
Journal of the American Pharmacists Association · 2026-07 · 66 (4) · 103166
DOI: 10.1016/j.japh.2026.103166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Pharmacists Association, 2026-07. Verfasst von A. Gant und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Gant, A., & Ndung’u, M. (2026). 114 Real-World Use of ACE Inhibitors and ARBs in Sickle Cell Disease: Evaluating Prescribing Patterns and Missed Opportunities in Microalbuminuria. Journal of the American Pharmacists Association, 66(4), 103166. https://doi.org/10.1016/j.japh.2026.103166
Vancouver
Gant A, Ndung’u M. 114 Real-World Use of ACE Inhibitors and ARBs in Sickle Cell Disease: Evaluating Prescribing Patterns and Missed Opportunities in Microalbuminuria. Journal of the American Pharmacists Association. 2026;66(4):103166. doi:10.1016/j.japh.2026.103166
BibTeX
@article{Gant2026,
author = {Gant, A. and Ndung’u, M.},
title = {114 Real-World Use of ACE Inhibitors and ARBs in Sickle Cell Disease: Evaluating Prescribing Patterns and Missed Opportunities in Microalbuminuria},
journal = {Journal of the American Pharmacists Association},
year = {2026},
volume = {66},
number = {4},
pages = {103166},
doi = {10.1016/j.japh.2026.103166}
}
EUVIMED